Delivery Order SPE2DB20D3505-SPE2DB24FU9A8
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $8,212.23 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $4,350.63 firm-fixed-price delivery order has a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $19,276.93 firm fixed price delivery order contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The $3,483.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order valued at $1,161.08 for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, placed by the Defense Logistics Agency (DLA). The contract has a period of performance through November 7, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,102.14 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract is a firm fixed-price agreement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. The $3,414.01 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. This is a delivery order contract and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) with the drug Ozempic (0.25-0.5 mg/dose pen 3ml) through a delivery order worth $6,961.44. The delivery order has a completion date of May 26, 2023 and uses a firm fixed price pricing type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3ml medication. The $14,832.32 firm fixed-price delivery order has an ultimate completion date of September 4, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract is a delivery order with a firm fixed price of $8,359.90 and an ultimate completion date of December 3, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...